NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
ENDRA Life Sciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.75+0.01 (+0.21%)
Close on Oct 19, 2026
- Market cap
- $11.76M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
10.2%
0M of 1M shares
Institutional holders
10
3 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| ASP Isotopes Inc. | 254,015 | 15.10% | 13D (active) | Oct 1, 2026 |
| Anthony DiGiandomenico | 196,692 | 9.90% | 13D (active) amendment | Jun 25, 2026 |
| ATW Master Fund V LP | 116,024 | 9.90% | 13G (passive) | Oct 16, 2025 |
| John Carter Lipman | 115,477 | 9.99% | 13G (passive) | Oct 23, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NDRA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Altium Capital Management LP | 59,272 | 3.95% | $315.92K | +7,372 | 0.67% |
| Citadel Advisors LLC | 29,924 | 2.00% | $159.50K | New | 0.00% |
| Citizens Financial Group Inc/Ri | 28,400 | 1.89% | $151.37K | New | 0.00% |
| Geode Capital Management, LLC | 14,910 | 0.99% | $79.47K | −6,168 | 0.00% |
| Vanguard Fiduciary Trust Co | 10,121 | 0.67% | $53.95K | – | 0.00% |
| Vanguard Capital Management LLC | 7,339 | 0.49% | $39.12K | +4,523 | 0.00% |
| Morgan Stanley | 3,546 | 0.24% | $18.90K | – | 0.00% |
| UBS Group AG | 68 | 0.00% | $362 | −84 | 0.00% |
| Tower Research Capital LLC (TRC) | 58 | 0.00% | $309 | New | 0.00% |
| Northwestern Mutual Wealth Management Co | 19 | 0.00% | $101 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10 | 0M | 10.2% | 3 / 2 | 2 / 1 | 0M | 0M |
| Q1 2026 | 8 | 0M | 6.0% | 4 / 1 | 1 / 2 | 0M | 0M |
| Q4 2025 | 7 | 0M | 4.8% | 4 / 1 | 2 / 2 | 0M | 0M |
| Q3 2025 | 5 | 0M | 0.9% | 2 / 0 | 1 / 0 | 0M | 0M |
| Q2 2025 | 3 | 0M | 0.3% | 2 / 1 | 0 / 1 | 0M | 0M |
| Q1 2025 | 2 | 0M | 0.1% | 1 / 0 | 0 / 3 | 0M | 0M |
| Q4 2024 | 4 | 0M | 0.0% | 4 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NDRA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 14,580 | 0.97% | $80.19K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 7,339 | 0.49% | $39.12K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 1,597 | 0.11% | $8.78K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Alexander Y. Tokman | Chief Executive Officer, Director | 101,926 | 6.80% | Mar 4, 2026 |
| Richard Jacroux | Chief Financial Officer | 33,461 | 2.23% | Mar 4, 2026 |
| Anthony Digiandomenico | Director | 136,589 | 9.11% | Jan 23, 2026 |
| Lou Basenese | Director | 65,709 | 4.38% | Jan 23, 2026 |
| Michael Harsh | Director | 65,710 | 4.38% | Jan 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Richard Jacroux Chief Financial Officer | Mar 2, 2026 | Award | +13,461 | – | – | 33,461 |
| Alexander Y. Tokman Chief Executive Officer, Director | Mar 2, 2026 | Award | +26,921 | – | – | 101,926 |
| Anthony Digiandomenico Director | Jan 21, 2026 | Award | +60,324 | – | – | 136,589 |
| Richard Jacroux Chief Financial Officer | Jan 21, 2026 | Award | +20,000 | – | – | 20,000 |
| Alexander Y. Tokman Chief Executive Officer, Director | Jan 21, 2026 | Award | +75,000 | – | – | 75,005 |
| Lou Basenese Director | Jan 21, 2026 | Award | +60,324 | – | – | 65,709 |
| Michael Harsh Director | Jan 21, 2026 | Award | +60,324 | – | – | 65,710 |
| Anthony Digiandomenico Director | Oct 10, 2025 | Award | +70,822 | $7.06 | $500.00K | 76,265 |
| Anthony Digiandomenico Director | Jun 11, 2025 | Award | +5,384 | – | – | 5,443 |
| Michael Harsh Director | Jun 11, 2025 | Award | +5,384 | – | – | 5,386 |
| Lou Basenese Director | Jun 11, 2025 | Award | +5,384 | – | – | 5,385 |
| Group AG UBS – | Aug 27, 2024 | Buy | +0 | – | – | 146,012 |
| Group AG UBS 10% owner | Aug 27, 2024 | Buy | +3,715 | $0.55 | $2.04K | 146,012 |
| Michael Milos Thornton Chief Technology Officer | May 18, 2023 | Buy | +15,000 | $1.65 | $24.75K | 34,139 |
| Anthony Digiandomenico Director | May 2, 2023 | Buy | +83,333 | $1.20 | $100.00K | 102,434 |
| Michael Milos Thornton Chief Technology Officer | Dec 9, 2022 | Buy | +1,500 | $3.40 | $5.10K | 19,139 |
| Alexander Y. Tokman Director | Nov 23, 2022 | Buy | +10,000 | $0.17 | $1.70K | 162,857 |
| Alexander Y. Tokman Director | Aug 22, 2022 | Buy | +20,000 | $0.26 | $5.20K | 152,857 |
| Michael Milos Thornton Chief Technology Officer | Aug 22, 2022 | Buy | +20,000 | $0.27 | $5.40K | 352,775 |
| Michael Milos Thornton Chief Technology Officer | May 26, 2022 | Buy | +25,000 | $0.21 | $5.25K | 332,775 |
| Michael Milos Thornton Chief Technology Officer | May 18, 2022 | Buy | +25,000 | $0.22 | $5.50K | 307,775 |
| Francois Roger Michelon Chief Executive Officer, Director | May 17, 2022 | Buy | +5,100 | $0.19 | $969 | 97,191 |
| Alexander Y. Tokman Director | May 16, 2022 | Buy | +100,000 | $0.20 | $20.00K | 132,857 |
| Lou Basenese Director | Aug 26, 2021 | Sale | −5,000 | $1.85 | $9.25K | 49,068 |
| Lou Basenese Director | Aug 25, 2021 | Sale | −45,000 | $1.83 | $82.35K | 54,068 |
| Michael Milos Thornton Chief Technology Officer | Apr 7, 2021 | Sale(10b5-1 plan) | −15,000 | $2.53 | $37.95K | 259,960 |
| Michael Milos Thornton Chief Technology Officer | Mar 29, 2021 | Sale(10b5-1 plan) | −18,750 | $2.37 | $44.44K | 274,960 |
| Michael Milos Thornton Chief Technology Officer | Feb 11, 2021 | Award | +22,815 | – | – | 316,525 |
| Michael Milos Thornton Chief Technology Officer | Jan 28, 2021 | Award | +22,815 | – | – | 316,525 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Jan 13, 2021 | Sale(10b5-1 plan) | −13,696 | $1.10 | $15.07K | 1,580 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Jan 12, 2021 | Sale(10b5-1 plan) | −6,304 | $1.05 | $6.62K | 15,276 |
| Alexander Y. Tokman Director | Jan 8, 2021 | Sale(10b5-1 plan) | −10,000 | $0.90 | $9.00K | 32,857 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Jan 8, 2021 | Sale(10b5-1 plan) | −8,731 | $0.94 | $8.21K | 21,580 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Jan 6, 2021 | Sale(10b5-1 plan) | −11,269 | $0.94 | $10.59K | 30,311 |
| David R. Wells Chief Financial Officer | Jan 6, 2021 | Sale(10b5-1 plan) | −34,900 | $0.90 | $31.41K | 80,003 |
| David R. Wells Chief Financial Officer | Jan 5, 2021 | Sale(10b5-1 plan) | −100 | $0.90 | $90 | 114,903 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Dec 17, 2020 | Sale(10b5-1 plan) | −25,000 | $0.73 | $18.25K | 41,580 |
| Francois Roger Michelon Chief Executive Officer, Director | Dec 4, 2020 | Sale(10b5-1 plan) | −71,519 | $0.83 | $59.36K | 92,091 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Nov 13, 2020 | Sale(10b5-1 plan) | −10,000 | $0.81 | $8.10K | 66,580 |
| Renaud Bertrand Maloberti Chief Commercial Officer | Oct 1, 2020 | Sale(10b5-1 plan) | −10,000 | $0.72 | $7.20K | 76,580 |
| Anthony Digiandomenico Director | Jul 21, 2020 | Option exercise | +100,503 | $0.87 | $87.44K | 382,012 |
| Michael Milos Thornton Chief Technology Officer | Jul 15, 2020 | Option exercise | +26,000 | $0.87 | $22.62K | 293,710 |
| David R. Wells Chief Financial Officer | Jun 23, 2020 | Option exercise | +5,000 | $0.87 | $4.35K | 115,003 |
| Michael Harsh Director | Jun 23, 2020 | Option exercise | +5,000 | $0.87 | $4.35K | 69,243 |
| Francois Roger Michelon Chief Executive Officer, Director | Jun 23, 2020 | Option exercise | +2,874 | $0.87 | $2.50K | 163,610 |
| Francois Roger Michelon Chief Executive Officer, Director | Jun 8, 2020 | Conversion | +5,175 | $0.87 | $4.50K | 160,736 |
| Michael Harsh Director | Jun 8, 2020 | Conversion | +11,386 | $0.87 | $9.91K | 64,243 |
| Michael Milos Thornton Chief Technology Officer | Jun 8, 2020 | Conversion | +51,747 | $0.87 | $45.02K | 267,710 |
| David R. Wells Chief Financial Officer | Jun 8, 2020 | Conversion | +10,350 | $0.87 | $9.00K | 110,003 |
| Anthony Digiandomenico Director | Jun 8, 2020 | Buy | +5,000 | $0.92 | $4.60K | 281,509 |
| Lou Basenese Director | May 29, 2020 | Buy | +10,000 | $0.90 | $9.00K | 99,068 |
| Lou Basenese Director | May 28, 2020 | Buy | +10,000 | $0.91 | $9.10K | 89,068 |
| Anthony Digiandomenico Director | May 28, 2020 | Buy | +5,000 | $0.90 | $4.50K | 276,509 |
| Lou Basenese Director | May 27, 2020 | Buy | +10,000 | $0.85 | $8.50K | 79,068 |
| Lou Basenese Director | May 26, 2020 | Buy | +10,000 | $0.82 | $8.20K | 69,068 |
| Anthony Digiandomenico Director | May 22, 2020 | Buy | +10,000 | $0.78 | $7.80K | 252,083 |
| Lou Basenese Director | May 21, 2020 | Buy | +10,000 | $0.71 | $7.10K | 59,068 |
| Lou Basenese Director | Apr 9, 2020 | Award | +41,587 | – | – | 41,587 |
| Michael Milos Thornton Chief Technology Officer | Apr 9, 2020 | Award | +96,213 | – | – | 215,963 |
| Anthony Digiandomenico Director | Apr 9, 2020 | Award | +42,857 | – | – | 242,083 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| DiGiandomenico Anthony Board Member | Jun 25, 2026 | 70,822 | $425.00K | Jun 26, 2026 | Private Placement |